Global Companion Diagnostics Market Top Players, Business Opportunities, Latest Industry Trends And Applications

-
A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment.
The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the companion diagnostics market.
The global companion diagnostics market is projected to reach USD 7.3 billion by 2024 from USD 3.5 billion in 2019, at a CAGR of 15.7%.
Market Dynamics – Drivers
  • Advantages of Companion Diagnostics
  • Growing Need for Targeted therapy
  • Growing Importance of Personalized Medicine
  • Increasing Global Incidence of Cancer
  • Growing Application Areas of Companion Diagnostics

Polymerase chain reaction (PCR) segment to account for the largest share of the companion diagnostics market, by technology, in 2019

The extractables/leachables testing services segment is expected to dominate the companion diagnostics market in 2019. The large share of this segment can be attributed to the ease of use and widespread availability of PCR kits & reagents in companion diagnostic testing, growing applications of PCR in the high-throughput detection of mutants with a limited or low allele frequency of genes, and high turnaround time of PCR as compared to other technologies.

Pharmaceutical & biopharmaceutical companies are estimated to be the largest end-users of companion diagnostics in 2019

Pharmaceutical & biopharmaceutical companies are expected to account for the largest share of the companion diagnostics market in 2019. The large share of this segment can majorly be attributed to the extensive usage of companion diagnostics in these industries owing to their growing prominence in drug development and the increasing importance of companion diagnostic biomarkers. The increasing demand for personalized medicine as well as the high demand for targeted therapies for various diseases and disorders are also expected to drive the demand and uptake of companion diagnostics among pharmaceutical & biopharmaceutical companies.

APAC market is estimated to grow at the highest CAGR during the forecast period

The companion diagnostics market in the APAC is estimated to grow at the highest CAGR during the forecast period. The high incidence of cancer, increasing proteomics & genomics research, growing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries are expected to drive the growth of the APAC market.
Leading Companies
The prominent players in the global companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), QIAGEN N.V. (Germany), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc., (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), Abnova Corporation (Taiwan), and Guardant Health, Inc. (US).
View Complete Press Release – Companion Diagnostics Market
Location: United States

Comments

Post a Comment

If you have any issue, Let me know ?

Popular posts from this blog

Laboratory Balances and Scales Market by Product (Balances (Analytical, Precision, Micro, Portable, Moisture) - Global Forecast to 2023

-
Image
According to the new market research report  " Laboratory Balances and Scales Market  by Product (Balances (Analytical, Precision, Micro, Portable, Moisture), Scales (Bench, Counting, Compact)), End User (Pharmaceutical, Biotechnology, Chemical, Beverage, Petroleum, Academia) - Global Forecast to 2023" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The major factors driving the growth of the laboratory balances and scales market are the technological advancements in laboratory balances and scales; increasing research investments and activities among pharma-biotech companies and CROs; increasingly stringent regulatory framework for product safety in bio-pharmaceutical industries; implementation of stringent food safety guidelines; and emerging markets. Based on product type, the laboratory balances market is segmented into m...
Read more

New Approach towards Technological Advancements in Ligation Devices Market

-
Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Ligation Devices Market Growth The  Global ligation devices market  is projected to reach $1,189 million by 2024 from $876 million in 2019, at a CAGR of 6.3%. Download PDF Brochures –  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22007372 Accessories – Ligation Devices The market is segmented into handheld instruments and accessories. The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period. This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets. Applications – Ligation Devices The market is segmented into gastrointestinal & abdominal surgeries...
Read more

Medical Holography Market is Future of Healthcare, it is Creating Real Change in the Healthcare Industry

-
According to a new market research report “ Medical Holography Market  by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021 ” published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021. The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures. In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holo...
Read more